Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.
Medicinal cannabis.
Charcot-marie-tooth disease type 1x in women: Electrodiagnostic findings.
Clinical and radiological features of recurrent demyelination following acute disseminated encephalomyelitis (ADEM).
Antibodies to aquaporin-1 are not present in neuromyelitis optica.
Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy.
Restless legs syndrome in Iranian multiple sclerosis patients: a case-control study.
Multitasking in Multiple Sclerosis: Can it Inform Vocational Functioning?
Activation of NOD2/RIPK2 pathway induces mitochondrial injury to oligodendrocyte precursor cells in vitro and CNS demyelination in vivo.
Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study.
Massive peripheral nerve hypertrophy in a patient with chronic inflammatory demyelinating polyradiculoneuropathy.
The challenges of measuring disability accumulation in relapsing-remitting multiple sclerosis: evidence from interferon beta treatments.
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic.
CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions.
Socioeconomic Factors in Childhood and the Risk of Multiple Sclerosis.
Family studies of type 1 diabetes reveal additive and epistatic effects between MGAT1 and three other polymorphisms.
Central nervous system involvement in primary Sjogren`s syndrome manifesting as multiple sclerosis.
A Review of the Psychometric Properties of Generic Utility Measures in Multiple Sclerosis.
Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials.
Oxidative damage to mitochondria at the nodes of Ranvier precedes axon degeneration in ex vivo transected axons.
A quantitative evaluation of damage in normal appearing white matter in patients with multiple sclerosis using diffusion tensor MR imaging at 3 T.
A critical period for social experience-dependent oligodendrocyte maturation and myelination.
Immunopathology of multiple sclerosis.
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients.
Pages
« first
‹ previous
…
517
518
519
520
521
522
523
524
525
…
next ›
last »